Transglutaminase 2 Mediates the Cytotoxicity of Resveratrol in a Human Cholangiocarcinoma and Gallbladder Cancer Cell Lines
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transglutaminase 2 Mediates the Cytotoxicity of Resveratrol in a Human Cholangiocarcinoma and Gallbladder Cancer Cell Lines
Authors
Keywords
-
Journal
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
Volume 70, Issue 5, Pages 761-769
Publisher
Informa UK Limited
Online
2018-05-14
DOI
10.1080/01635581.2018.1470648
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy
- (2017) Dipak D. Meshram et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Primary sclerosing cholangitis – a comprehensive review
- (2017) Tom H. Karlsen et al. JOURNAL OF HEPATOLOGY
- Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update
- (2017) Aarti Sharma et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Resveratrol-based combinatorial strategies for cancer management
- (2013) Chandra K. Singh et al. Annals of the New York Academy of Sciences
- Resveratrol and cellular mechanisms of cancer prevention
- (2011) Yogeshwer Shukla et al. Annals of the New York Academy of Sciences
- Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases--Safety, Pharmacokinetics, and Pharmacodynamics
- (2011) L. M. Howells et al. Cancer Prevention Research
- Resveratrol and health - A comprehensive review of human clinical trials
- (2011) James M. Smoliga et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Analysis of anticancer drugs: A review
- (2011) Susanne Nussbaumer et al. TALANTA
- Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
- (2010) K. R. Patel et al. CANCER RESEARCH
- Cardiac side-effects of cancer chemotherapy
- (2010) Jean-Jacques Monsuez et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease
- (2010) Luca Elli et al. LABORATORY INVESTIGATION
- Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents
- (2010) Gabriel A Frampton et al. LABORATORY INVESTIGATION
- Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line
- (2010) Leda Roncoroni et al. LIVER INTERNATIONAL
- Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis
- (2009) Ji Hoon Jang et al. CANCER LETTERS
- Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
- (2009) A. Bishayee Cancer Prevention Research
- Transglutaminase 2 Is Central to Induction of the Arterial Calcification Program by Smooth Muscle Cells
- (2008) Kristen A. Johnson et al. CIRCULATION RESEARCH
- A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice
- (2008) Jamie L. Barger et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started